术前使用他汀与非心脏手术后90天死亡率的关系
这项回顾性队列研究分析了一家三级学术医院2012至2018年择期非心脏手术成人患者的病历,经倾向评分匹配后纳入33,514例患者(每组16,757例)。结果显示,他汀组90天死亡风险较非他汀组降低26%(OR 0.74,95%CI 0.59-0.92,P=0.009),高剂量强度他汀组降低61%(OR 0.39,95%CI 0.18-0.84,P=0.016),且他汀组总生存时间显著更长(P<0.001)。
要点
- 术前使用他汀与择期非心脏手术后90天死亡率降低相关。
- 高剂量强度他汀使用者的死亡风险降低更为明显。
- 他汀组总生存时间显著长于非他汀组。
核心结论
- 术前使用他汀与成人择期非心脏手术后90天死亡率降低及总生存时间延长相关。
- 该关联在高剂量强度他汀使用者中更为明显。
研究设计与样本
- 回顾性队列研究,分析单家三级学术医院2012年1月至2018年12月择期非心脏手术成人患者的病历。
- 经倾向评分匹配后共纳入33,514例患者,他汀组与非他汀组各16,757例。
主要发现
- 倾向评分匹配队列的逻辑回归分析显示,他汀组90天死亡率的比值比(OR)较非他汀组低26%(OR 0.74;95%CI 0.59-0.92;P=0.009)。
- 敏感性分析显示,高剂量强度他汀组90天死亡率较非他汀组低61%(OR 0.39;95%CI 0.18-0.84;P=0.016)。
- 倾向评分匹配后,他汀组总生存时间显著长于非他汀组(log-rank检验P<0.001)。
临床怎么用
- 对于拟行择期非心脏手术的成人患者,术前他汀使用可能与术后90天死亡率降低相关,高剂量强度使用者可能获益更明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the association between preadmission statin use and 90-day mortality after planned elective noncardiac surgery in adult patients. SUMMARY BACKGROUND DATA: Statin therapy is known to have pleiotropic effects, which improve the outcomes of various diseases. However, the effect of perioperative statin therapy on postoperative mortality remains controversial. METHODS: This retrospective cohort study analyzed the medical records of adult patients who were admitted to a single tertiary academic hospital for elective noncardiac surgery between January 2012 and December 2018. The primary endpoint was 90-day mortality, which was defined as any mortality within 90 days after surgery. The secondary endpoint was overall survival. RESULTS: After propensity score matching, a total of 33,514 patients (16,757 patients in each group) were included in the analysis. The logistic regression analysis of the propensity score-matched cohort indicated that the odds ratio (OR) of 90-day mortality in the statin group was 26% lower than that of the nonstatin group [OR: 0.74; 95% confidence interval (CI): 0.59 to 0.92; P = 0.009]. The sensitivity analysis indicated that the high-dose intensity statin group had a 61% lower 90-day mortality rate than the nonstatin group (OR: 0.39; 95% CI: 0.18-0.84; P = 0.016). The overall survival time was significantly longer in the statin group than in the nonstatin group after propensity score matching (P < 0.001 by log-rank test). CONCLUSIONS: Preoperative statin use was associated with lower 90-day mortality and longer overall survival for adult patients who underwent elective noncardiac surgery. This association was more evident for high-intensity statin users.
引用
- Im C, Oh TK, Song IA, et al. Preoperative Statin Use and 90-Day Mortality After Noncardiac Surgery: A Hospital Registry Study. Ann Surg. 2021. PMID: 31850989. doi:10.1097/SLA.0000000000003737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。